A Randomized Trial of Single- and Two-Dose Ivermectin versus Thiabendazole for Treatment of Strongyloidiasis

A randomized trial is described comparing ivermectin and thiabendazole for treatment of chronic infection with Strongyloides stercoralis. Subjects received ivermectin (200 µg/kg) in a single dose, ivermectin (200 µg/kg) on 2 consecutive days, or thiabendazole (50 mg/kg/day) twice daily for 3 consecu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 1994-05, Vol.169 (5), p.1076-1079
Hauptverfasser:	Gann, Peter H., Neva, Franklin A., Gam, Albert A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged AIDS Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antibodies Antiparasitic agents Biological and medical sciences Child Child, Preschool Dose-Response Relationship, Drug Epidemiology Female Follow-Up Studies HIV Human T lymphotropic virus 1 Human T lymphotropic virus 2 Humans Infections Ivermectin - therapeutic use Major Articles Male Medical sciences Middle Aged Pharmacology. Drug treatments Sexually transmitted diseases Strongyloides stercoralis Strongyloidiasis - drug therapy T lymphocytes Thiabendazole - therapeutic use Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!